HEAL-LAA Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 949 participants.
Also called NCT05809596
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 949 participants
- Sponsor
- Registry
-
NCT05809596
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05809596. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-03 (actual); primary completion 2024-07-15 (actual). Results posted on 2025-10-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HEAL-LAA Clinical Trial
- Acronym
- HEAL-LAA
- Condition
- Atrial Fibrillation
- Condition
- Bleeding
- Condition
- Stroke
- Intervention (Device)
- WATCHMAN FLX Pro LAAC Device
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct05809596- Content hash
9b3568289b854ff5403e7313833e8a2d7316d1e34e9c18278faff04508e27a9c